Top Markets
Coin of the day
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Peringkat dalam Saham #40615
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Harga Saham
$0.13607016
Terakhir disinkronkan: 2024-09-10
Kapitalisasi Pasar
$112.29K
Perubahan (1 hari)
22.46%
Perubahan (1 tahun)
0.00%
Negara
GB
Perdagangan BiVictriX Therapeutics Plc (BVX)

Kategori

Harga BVX dengan kapitalisasi pasar B
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
BVX
$0.13607016
Kapitalisasi pasar dari BiVictriX Therapeutics Plc(BVX)
Kapitalisasi Pasar: $112.29K
Per August 2026, BiVictriX Therapeutics Plc memiliki kapitalisasi pasar sebesar $112.29K. Ini menjadikan BiVictriX Therapeutics Plc sebagai perusahaan 40615th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar BiVictriX Therapeutics Plc dari 2021 hingga 2026
BVX dibandingkan dengan 5 teratas stocks paling populer
Harga BVX Aset B Pasar B Hasil
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$6,623,006 $112.29K
$5.466T +4,867,346,307.19%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$5,399,500 $112.29K
$4.456T +3,968,173,637.66%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$5,058,556 $112.29K
$4.175T +3,717,608,716.22%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$4,468,567 $112.29K
$3.688T +3,284,016,629.46%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$3,471,163 $112.29K
$2.865T +2,551,009,819.51%